Literature DB >> 3704541

Irreversible ototoxic effect of erythromycin.

G Levin, E Behrenth.   

Abstract

Between 30 and 40 cases of reversible ototoxic side effects of erythromycin therapy have been reported previously but to our knowledge none with irreversible adverse reactions. A case of persistent tinnitus after intravenous erythromycin therapy is reported in the following.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3704541     DOI： 10.3109/01050398609045952

Source DB:  PubMed          Journal:  Scand Audiol        ISSN： 0105-0397


  8 in total

Review 1.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

2.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

3.  Irreversible sensorineural hearing loss due to erythromycin.

Authors:  J Dylewski
Journal:  CMAJ       Date:  1988-08-01       Impact factor: 8.262

Review 4.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 5.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 6.  Drug-induced ototoxicity. Pathogenesis and prevention.

Authors:  M Y Huang; J Schacht
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 7.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003

8.  Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss.

Authors:  Anna Vanoverschelde; Berthe C Oosterloo; Nelly F Ly; M Arfan Ikram; André Goedegebure; Bruno H Stricker; Lies Lahousse
Journal:  J Antimicrob Chemother       Date:  2021-09-15       Impact factor: 5.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.